# Zivo Bioscience, Inc.: Form 8-K, filed Nov 22, 2023

- Company: [Zivo Bioscience, Inc.](/companies/zivo.md) (CIK 1101026)
- Form: 8-K
- Filed: 2023-11-22
- Accepted by EDGAR: Nov 22, 2023, 16:21 ET
- Period: 2023-11-16
- Accession: 0001654954-23-014712
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1101026/000165495423014712/zivo_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1101026/000165495423014712/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1101026/000165495423014712/zivo_8k.htm

Filed Nov 22, 2023.
Source: SEC EDGAR, the filing index for accession 0001654954-23-014712. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
